On November 20, vTv Therapeutics Announced A 1-For-40 Reverse Stock Split
Portfolio Pulse from Benzinga Newsdesk
vTv Therapeutics Inc. implemented a 1-for-40 reverse stock split on November 20, 2023, to regain compliance with Nasdaq's minimum share price requirement. The reverse split affected both Class A and Class B common stock, with fractional shares rounded up. The post-split trading of Class A common stock under the symbol 'VTVT' with a new CUSIP number began on November 21, 2023.
November 21, 2023 | 4:31 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
vTv Therapeutics conducted a 1-for-40 reverse stock split to comply with Nasdaq's minimum price rule. Trading on a post-split basis started on November 21, 2023, under the same ticker with a new CUSIP number.
The reverse stock split is a neutral to slightly positive event as it is a technical adjustment to comply with Nasdaq's listing requirements. While it does not fundamentally alter the company's value, it may improve market perception by maintaining its listing status. The impact is neutral short term as the market has likely already anticipated this move since it was previously announced.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100